Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied screen. This means users cannot view the trial information or related content on that page.SummaryDifference20%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAn NIH grant/contract identifier (2014) was added to the study identifiers, and the page now reflects Revision: v3.6.6, replacing the prior v3.6.5.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4, representing a small update to the posted page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page shows a new Revision: v3.6.4 label, replacing the previous Revision: v3.6.3, indicating a minor system update to the page's version labeling.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, reflecting a new release version of the page. This change indicates a small update to the page's underlying software or documentation without modifying study information.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now shows a new revision tag v3.6.2 and the older tag v3.6.0 has been removed, updating the page's version indicator.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.